Letters
Audit is important part of drug safety and regulation
BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7514.456 (Published 18 August 2005) Cite this as: BMJ 2005;331:456
- Michael I Carter, consultant anaesthetist (Michael.Carter@ldh-tr.anglox.nhs.uk),
- Jane Murkin, patient safety manager
- Luton and Dunstable Hospital NHS Trust, Luton LU4 0DZ
- Luton and Dunstable Hospital NHS Trust, Luton LU4 0DZ
EDITOR—Waller et al write about the responsibilities of the pharmaceutical companies and the regulating agencies such as the UK Medicines and Healthcare products Regulatory Agency to improve the safety of the drugs that are licensed for prescription.1 Although cyclo-oxygenase 2 inhibitors and selective serotonin reuptake inhibitors have been under the spotlight in recent months, other drugs may be of greater concern.
In …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.